Trial Profile
Study of cognitive functions , BPSD and burden of care for caregivers in the additional dosage of the memantine hydrochloride for the Alzheimer's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jun 2022
Price :
$35
*
At a glance
- Drugs Memantine (Primary) ; Acetylcholinesterase inhibitors
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 27 Jun 2022 Status changed from active, no longer recruiting to completed.
- 11 Dec 2015 New trial record